Corpora-amylacea and the family of polyglucosan diseases

Brain Research Reviews

Volumn 29, Issue 2-3, 1999, Pages 265-295

  Cavanagh, J B ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Aging process; Bielschowsky body; Corpora amylacea of brain; Lafora body; Polyglucosan body

Indexed keywords

AMYLOID BODY; ASTROCYTE; CELL INCLUSION; CELL ULTRASTRUCTURE; GLYCOGEN STORAGE DISEASE TYPE 4; HEART MUSCLE CELL; HUMAN; LIVER; LUNG; MYOCLONUS EPILEPSY; NERVE CELL; NEUROPATHOLOGY; PRIORITY JOURNAL; PROSTATE; PROTEIN DEGRADATION; REVIEW; SKELETAL MUSCLE; THYROID GLAND; TISSUE DISTRIBUTION;

ANIMALS; BRAIN; HUMANS; INCLUSION BODIES; NERVOUS SYSTEM;

EID: 0032937953     PISSN: 01650173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0173(99)00003-X     Document Type: Review

References (231)

1. Abe H., Yagashita S. Massive appearance of corpora amylacea in postnatal anoxic encephalopathy. Clin. Neuropathol. 14:1995;207-210.
2. Alder N. On the nature, origin and distribution of the corpora amylacea of the brain with observations on some new staining reactions. J. Mental Sci. 99:1953;689-697.
3. Adler D., Horoupian D.S., Towfighi J., Gandolfi A., Suzuki K. Status marmoratus and Bielschowsky bodies. A report of two cases and review of the literature. Acta Neuropathol. 56:1982;75-77.
4. Andersen D.H. Familial cirrhosis of the liver with storage of abnormal glycogen. Lab. Invest. 5:1956;11-20.
5. Antal M. Observations sur les corps de Lafora dans la retine de divers animaux. Journal Français Ophtalmologique. 5:1982;615-620.
6. Anzil A.P., Herrlinger H., Blinzinger K., Kronski D. Intraneuritic corpora amylacea. Virchows Arch. A. Pathol. Anat. Histol. 364:1974;297-301.
7. Astrom K.E., Kugelberg E., Muller R. Hypothyroid myopathy. Arch. Neurol. 5:1961;472-482.
8. Atsumi T. The ultrastructure of intramuscular nerves in amyotrophic lateral sclerosis. Acta Neuropathol. 55:1981;193-198.
9. Avendano J., Rodrigues M.M., Hackett J.J., Gaskins R. Corpora amylacea of the optic nerve and retina: A form of neuronal degeneration. Invest. Ophthalmol. Vis. Sci. 19:1980;550-555.
10. Averback P. Parasynaptic corpora amylacea in the striatum. Arch. Pathol. 105:1981;334-335.
11. Averback P. Dense microspheres in normal human brain. Acta Neuropathol. 61:1983;148-152.
12. Averback P., Langevin H. Corpora amylacea of the lumbar spinal cord and peripheral nervous system. Arch. Neurol. 35:1978;95-96.
13. Bao Y., Kishnani P., Wu J.Y., Chen Y.T. Hepatic and neuromuscular forms of glycogen-storage-disease type-IV caused by mutations in the same glycogen branching enzyme gene. J. Clin. Invest. 97:1996;941-948.
14. Barz H., Kemmer C., Kunze D., Sachs B. Amyotrophe Lateralsklerose im Myoklonuskörpern. Ztlblatt f. Allg. Path. u Path. Anat. 120:1976;333-342.
15. Benkovic S.A., Connor J.R. Ferritin, transferrin and iron in selected regions of the adult and aged rat. J. Comp. Neurol. 338:1993;97-113.
16. Bernsen R.A.J.A.M., Busard H.L.S.M., Ter Laak H.J., Gabreëls F.J.M., Renier W.O., Joosten E.M.G., Theeuwes A.G.M. Polyglucosan bodies in intramuscular motor nerves. Acta Neuropathol. 77:1989;629-633.
17. Bielschowsky M. Beiträge zur Histopathologie der Ganglionzellen. J. Psychol. Neurol. (Leipzig). 18:1912;513-521.
18. Blakemore W.F. Observations on oligodendrocyte degeneration, the resolution of status spongiosus and remyelination in cuprizone intoxication in mice. J. Neurocytol. 1:1972;413-426.
19. Blakemore W.F., Palmer A.C., Noel P.R.B. Ultrastructural changes in isoniazid induced oedema in the dog. J. Neurocytol. 1:1972;263-278.
20. Bornemann A., Besser R., Shin Y.S., H Goebel H. A mild adult myopathic variant of Type IV glycogenosis. Neuromuscular Disord. 6:1996;95-99.
21. Brawer J.R., Reichard G., Small L., Schipper H.M. The origin and composition of peroxidase-positive granules in cysteamine-treated astrocytes in culture. Brain Res. 633:1994;9-20.
22. Brewer Myxoedema D.B. An autopsy report with histochemical observations on the nature of the mucoid infiltrations. J. Pathol. Bacteriol. 63:1951;502-512.
23. Brit J.O., Paster M.B., Gonzales C. Lafora Body neuropathy in a cockatiel. Comp. Animal Pract. 19:1989;31-33.
24. Brown B.I., Brown D.H. Lack of an alpha-1,4-glucan; alpha-1,6 -glucan 6-glycosyl transferase in a case of type IV glycogenosis. Proc. Natl. Acad. Sci. 56:1966;725-729.
25. Brown D.R., Brown B.I. Studies of the residual glycogen branching enzyme activity present in human skin fibroblasts from patients with type IV glycogen storage disease. Biochem. Biophys. Res. Commun. 111:1983;636-643.
26. Bruno C., Servidei S., Shanske S., Karpati G., Carpenter S., McKee D., Barohn R.J., Hirano M., Rifai Z., DiMauro S. Glycogen branching enzyme deficiency in adult polyglucosan body disease. Ann. Neurol. 33:1993;88-93.
27. Busard H.L., Renier W.O., Gabreëls F.J.M., Jaspar H.H.J., Sloof J.L., Janssen A.J.M., van Haelst U.J.G. Lafora disease: a quantitative morphological and biochemical study of the cerebral cortex. Clin. Neuropathol. 6:1987;1-6.
28. Busard H.L.S.M., Gabreëls-Festen A.A., van-'t-Hof M.A., Renier W.O., Gabreëls F.J.M. Polyglucosan bodies in sural nerve biopsies. Acta Neuropathol. 80:1990;554-557.
29. Busard H.L.S.M., Span J.P.T., Renkawek K., Renier W.O., Gabreëls F.J.M., Sloof J.L., van't Hof M.A. Polyglucosan bodies in brain tissue: a systematic study. Clin. Neuropathol. 13:1994;60-63.
30. E.F. Buzzard, J.G. Greenfield, Pathology of the Nervous System. Constable and London, 1921.
31. Cafferty M.S., Lovelace R.E., Hays A., Servidei S., DiMauro S., Rowland L.P. Polyglucosan body disease. Muscle Nerve. 14:1991;102-107.
32. Carpenter S., Karpati G., Andermann F., Jacob J.C., Andermann E. Lafora's disease: peroxisomal storage in skeletal muscle. Neurology. 24:1974;531-538.
33. Carpenter S., Karpati G. Sweat gland duct cells in Lafora Disease: diagnosis by skin biopsy. Neurology. 31:1981;1564-1568.
34. Catola G., Achúcarro N. Über die Enstehung de Amyloidkörperchen in Zentralnervensystem. Virchows Arch. f. Path. Anat. 184:1906;454-469.
35. Cavanagh J.B. Spinal corpora amylacea and Motor Neuron Disease: a quantitative study. J. Neurol. Neurosurg. Psychiatry. 65:1998;488-491.
36. Cavanagh J.B., Blakemore W.F., Kyu M.H. Fibrillary accumulations in oligodendroglial processes of rats subjected to portocaval anastomosis. J. Neurol. Sci. 14:1971;143-152.
37. Cavanagh J.B., Gysbers M.F. Ultrastructural changes in axons caused by acrylamide above a nerve ligature. Neuropathol. Appl. Neurobiol. 7:1981;315-326.
38. Cavanagh J.B., Gysbers M.F. Ultrastructure of Purkinje cells damaged by acrylamide in the rat: a new phenomenon in cellular neuropathology. J. Neurocytol. 12:1983;413-437.
39. Cavanagh J.B., Nolan C.C., Brown A.W. Glial cell intrusions actively remove detritus due to toxic chemicals from within nerve cells. Neurotoxicology. 11:1990;1-12.
40. Cavanagh J.B., Nolan C.C., Seville M.P., Anderson V.E.R., Leigh P.N. Routes of excretion of neuronal lysosomal dense bodies after ventricular infusion of leupeptin in the rat: a study using ubiquitin and PGP 9.5 immunocytochemistry. J. Neurocytol. 22:1993;779-791.
41. J.B. Cavanagh, H.B. Jones, Glycogenosomes in the rat brain, 1999, unpublished study.
42. Chung M.H., Horoupian D.S. Corpora amylacea: a marker for mesial temporal sclerosis. J. Neuropathol. Exp. Neurol. 55:1996;403-408.
43. Cisse S., Lacoste-Royal G., Laperrière J., Cabana T., Gavreau D. Ubiquitin is a component of polypeptides purified from corpora amylacea of aged human brain. Neurochem. Res. 16:1991;429-433.
44. Cisse S., Perry G., Lacoste-Royal G., Cabana T., Gavreau D. Immunochemical identification of ubiquitin and heat-shock proteins in corpora amylacea from normal aged and Alzheimer's disease brains. Acta Neuropathol. 85:1993;233-240.
45. Cisse S., Schipper H.M. Experimental induction of corpora amylacea-like inclusions in rat astroglia. Neuropathol. Appl. Neurobiol. 21:1995;423-431.
46. Coleman D.L., Gambetti P., Mauro S.D., Blume R.E. Muscle in Lafora disease. Arch. Neurol. 31:1974;396-406.
47. Collins G., Cowden R., Nevis A. Myoclonus epilepsy with Lafora bodies: an ultrastructural and cytochemical study. Arch. Pathol. 86:1968;239-254.
48. Coquet M., Vallat J.M., Latapie J.L. Basophilic inclusions in skeletal muscle from two cases of hypothyroid myopathy. Acta Neuropathol. Suppl. VII:1981;320-322.
49. de León G.A. Bielschowsky bodies: Lafora-like inclusions associated with atrophy of the lateral pallidum. Acta Neuropathol. 30:1974;183-188.
50. de León G.A., Crawford S.E., Stack C., Darling C.F., Johnson S. Amylaceous (Polyglucosan) bodies in familial cerebral atrophy of early onset. J. Child Neurol. 11:1996;58-62.
51. Dolman C.L., McCormick Q., Drance S.M. Aging of the optic nerve. Arch. Ophthalmol. 98:1980;2053-2058.
52. Drury I., Blaivas M., Abou-Khalil B.W., Beydoun A. Biopsy results in a kindred with Lafora Disease. Arch. Neurol. 50:1993;102-105.
53. Dubois-Dalcq M. Étude histochimique des corps de Lafora. Acta Neuropathol. 12:1969;205-217.
54. Eiberg H., Mohr J., Nielson L.S. Linkage of plasma alpha-L-fucosidase (FUCA2) and the plasminogen (PLG) system. Clin. Genet. 26:1984;23-29.
55. Ewing J.F., Maines M.D. Glutathione depletion induces heme oxygenase-1 (HSP32) mRNA and protein in rat brain. J. Neurochem. 60:1993;1512-1519.
56. Felice K.J., Grunnet M.L., Rao K.R., Wolfson L.I. Childhood-onset spinocerebellar syndrome associated with massive polyglucosan body deposition. Acta Neurol. Scand. 95:1997;60-64.
57. Ferrans V.J., Hibbs R.G., Walsh J., Burch G.E. Cardiomyopathy, cirrhosis of the liver and deposits of a fibrillar polysaccharide. Am. J. Cardiol. 17:1966;457-469.
58. Ferraro A., Damon L.A. The histogenesis of amyloid bodies in the central nervous system. Arch. Pathol. 12:1931;229-244.
59. Field E.J., Raine C.S., Joyce G. Scrapie in the rat: an electron microscopic study: I. Amyloid bodies and deposits. Acta Neuropathol. 8:1967;47-56.
60. W. Ford Robertson, A Textbook of Pathology in Relation to Mental Disease. W.F. Clay, Edinburgh, 1900.
61. Fujii M., Goto N., Okada A., Kida A., Kikuchi K. Distribution of amyloid bodies in the aged human vestibulocochlear nerve. Acta Oto-Laryngol. 116:1996;566-571.
62. Gallen C.C., Schultz P., Thomas C.S., Jones M., Brown B.I. Glycogenosis IV: clinical and pathological findings in siblings. Ann Neurol. 20:1986;404.
63. Gambetti P., Di Mauro S., Hirt L., Blume R.P. Myclonic epilepsy with Lafora bodies. Arch. Neurol. 25:1971;483-493.
64. Geipel P. Untersuchungen über rheumatische Myokarditis. Dtschs Arch. Klin. Med. 85:1905;75-88.
65. Gertz H.J., Cervos-Navarro J., Frydal V., Schultz F. Glycogen accumulation of the aging brain. Mech. Ageing Dev. 31:1985;25-35.
66. Goebel H.H., Shin Y.S., Gullotta F., Yokota T., Alroy J., Voit T., Haller P., Schulz A. Adult polyglucosan body myopathy. J. Neuropathol. Exp. Neurol. 51:1992;24-35.
67. Gray E.G. The fine structure of nerve. Comp. Biochem. Physiol. A. 36:1970;419-448.
68. Gray F., Gherardi R., Marshall A., Janota I., Poirie J. Adult polyglucosan body disease (APBD). Neuropathol. Exp. Neurol. 47:1988;459-474.
69. Greene V., Papasozomenos S.C. Tau-protein immunoreactivity in Lafora body disease and in corpora amylacea. J. Neuropathol. Exp. Neurol. 46:1987;345. Abstr.
70. Grover-Johnson N., Spencer P.S. Peripheral nerve abnormalities in aging rats. J. Neuropathol. Exp. Neurol. 40:1981;155-165.
71. Gueft B. The X-ray diffraction pattern of prostatic corpora amylacea. Acta Pathol. Microbiol. Scand. A. 233:1972;132-134.
72. Hara M. Microscopic globular bodies in the human brain. J. Neuropathol. Exp. Neurol. 45:1986;169-178.
73. Harriman D.G.F., Millar J.H.D. Progressive familial myoclonic epilepsy in three families; its clinical and pathological basis. Brain. 78:1955;325-349.
74. Haumeder M.E. Basophilic degeneration of heart muscle. Am. J. Pathol. 11:1935;535-540.
75. Haust M.D., Rowlands D.T., Garancis J.C., Landing B.H. Histochemical studies on cardiac 'colloid'. Am. J. Pathol. 40:1962;185-197.
76. Hegreberg G.A., Padgett G.A. Inherited progressive epilepsy of the dog with comparisons to Lafora's disease in man. Fed. Proc. 35:1976;1202-1205.
77. A. Hirano, The pathology of the central nervous system, in: G.H. Bourne (Ed.), Structure and Function of the Nervous System, 5, Academic Press, New York, 1972, 73-163.
78. Hirano A., Zimmerman H.M. Some new pathological findings in the central myelinated axon. J. Neuropathol. Exp. Neurol. 30:1971;63-67.
79. Ho K.L. Basophil degeneration in skeletal muscle in hypothyroid myopathy. Arch. Pathol. Lab. Med. 108:1984;239-245.
80. Holland J.M., William D.V.M., Davis C., Prieur D.J., Collins G.H. Lafora Disease in a dog: a comparative study. Am. J. Pathol. 58:1970;509-529.
81. Hollander D.H., Hutchins G.M. Central spherules in pulmonary corpora amylacea. Arch. Pathol. Lab. Med. 102:1978;630-639.
82. Iannaccone S., Zucconi M., Quattrini A., Nemni R., Comola M., Taccagni L., Smirne S. Early detection of skin and muscular involvement in Lafora disease. J. Neurol. 238:1991;217-220.
83. J.M. Innes, L.Z. Saunders, Comparative Neuropathology, Academic Press, New York, 1962.
84. Iwaki T., Hamada Y., Tateishi J. Advanced glycation end-products and heat-shock proteins accumulate in the basophilic degeneration of the myocardium and the corpora-amylacea of the glia. Pathol. Int. 46:1996;757-763.
85. Jackson M.C., Kucera C.M., Lenney J.F. Purification and properties of human serum carnosinase. Clin. Chim. Acta. 196:1991;193-205.
86. Jackson M.C., Scollard D.M., Mack R.J., Lenney J.F. Localization of a novel pathway for the liberation of GABA in the human CNS. Brain Res. Bull. 33:1994;379-385.
87. Jacobs J.M., Cavanagh J.B. Aggregations of filaments in Schwann cells of spinal roots of the normal rat. J. Neurocytol. 1:1973;161-167.
88. Janeway R., Ravens J.R., Pearce L.A., Oder D.L., Suzuki K. Progressive myoclonus epilepsy with Lafora inclusion bodies. Arch. Neurol. 16:1967;565-582.
89. Jenis E.H., Schochet S.S., Earle K.M. Myoclonus epilepsy with Lafora bodies: case report with electron microscopic observation. Military Med. 135:1970;116-119.
90. Jian Z., Alley M.R., Cayzer J., Swinney G.R. Lafora disease in an epileptic Basset hound. New Zealand Vet. J. 38:1990;75-79.
91. Jucker M., Walker L.C., Martin L.J., Kitt C.A., Kleinman H.K., Ingram D.K., Price D.L. Age associated inclusions in normal and transgenic mouse brains. Science. 255:1992;1443-1445.
92. Jucker M., Walker L.C., Kuo H., Tian M., Ingram D.K. Age-related fibrillar deposits in brains of c57bl/6 mice-a review of localization, staining characteristics, and strain specificity. Mol. Neurobiol. 9:1994;125-133.
93. Kamiya S., Suzuki Y. Polyglucosan bodies in the central nervous system of the fox. J. Comp. Pathol. 105:1991;467-470.
94. Kaufman M.A., Dwork A.J., Willson N.J., John S., Liu J.D. Late onset Lafora's Disease. Neurology. 43:1993;1246-1248.
95. Kay M.M.B. Isolation of the phagocytosis inducing IGG-binding antigen on senescent somatic cells. Nature (Lond.). 289:1981;491-494.
96. Kay M.M.B. Generation of senescent cell antigen on old cells initiates IGG binding to a neoantigen. Cell Mol. Biol. 39:1993;131-153.
97. ε-(carboxylmethyl)lysine and pentosidine, in age-related inclusions in human brain. Pathol. Int. 48:1998;575-579.
98. R.H.M. King, Changes in the peripheral nervous system, in: U. Mohr, D.L. Dungworth, C.C. Caper (Eds.), Pathobiology of the Aging Rat, 2, ILSI Press, WA 199, 335-53.
99. E.H. Kolodny, Metachromatic leucodystrophy and multiple sulfatase deficiency: sulfatide lipidosis. in: C.R. Scriver, A.L. Beaudet, W.S. Sly, D. Valle (Eds.), The Metabolic Basis of Inherited Disease 6th edn. New York, McGraw Hill, 1989, 1721-1749.
100. Komure O., Ichikawa K., Tsutsumi A., Hiyama K., Fujioka A. Intra-axonal polysaccharide deposits in the peripheral nerve seen in adult polysaccharide storage myopathy. Acta Neuropathol. 65:1985;300-304.
101. Kosaka K., Matsushita M., Oyanagi S., Uchiyama S., Iwase S. Pallido-nigro-luysial atrophy with massive appearance of corpora amylacea in the CNS. Acta Neuropathol. 53:1981;169-172.
102. Koskiniemi M., Donner M., Majuri H., Haltia M., Norio R. Progressive myoclonus epilepsy: clinical and histopathological study. Acta. Neurol. Scand. 50:1974;307-332.
103. Kreeger J.M., Frappier D.C., Kendall J.D. Systemic glycoproteinosis resembling Lafora's disease in a cow. Cornell Vet. 81:1991;215-221.
104. Kubota T., Naumann G.O.H. Reduction in number of corpora amylacea with advancing histological changes of glaucoma. Graefe's Arch. Clin. Exp. Ophthalmol. 231:1993;249-253.
105. Kubota T., Holbach L.M., Naumann G.O.H. Corpora amylacea in glaucomatous and non-glaucomatous optic nerve and retina. Graefe's Arch. Clin. Exp. Ophthalmol. 231:1993;7-11.
106. Lafora G.R. Über das Vorkommen amyloider Körperschen im Innern der Ganglienzellen. Ein Beitrag zum Studium der amyloiden Substanz im Nervensystem. Virchows Archiv (A). 205:1911;295-303.
107. Lafora G.R., Glück B. Beitrag zur Histopathologie der myoklonischen Epilepsie. Z. Ges. Neurol. Psychiat. 6:1911;1-14.
108. Lafora G.R. Nuevas investigaciones sobre los cuerpos amiláceos del interior de las celulas nerviosas. Trab. Lab. Invest. Biológ. Univ. Madrid. 11:1913;29-42.
109. Lamar C.H., Hinsmann E.J., Henrikson C.K. Alteration in the hippocampus of aged mice. Acta Neuropathol. 36:1976;387-391.
110. Leel-Össy L. Pathological significance and characteristics of corpus amylaceum. Neuropatholgy. 11:1991;105-114.
111. Lehesjoki A.-E., Koskiniemi M., Sistonen P., Miao J., Hästacka J., Norio R., de la Chapelle A. Localisation of a gene for progressive myoclonus epilepsy to chromosome 21q22. Proc. Natl. Acad. Sci. U.S.A. 88:1991;3696-3699.
112. Lehesjoki A.-E., Koskiniemi M., Pandolfo M., Antonelli A., Kyllerman M., Wahlström J., Nergårdh A., Burmeister M., Sistonen P., Norio R., de la Chapelle A. Linkage studies in progressive myoclonic epilepsy: Unverricht-Lundborg and Lafora diseases. Neurology. 42:1992;1545-1550.
113. Lewis P.D., Evans D.J., Shamnayati B. Immunocytochemical anti-lectin-binding studies on Lafora bodies. Clin. Neuropathol. 9:1990;7-9.
114. Liu H.M., Anderson K., Caterson B. Demonstration of a keratin sulfate proteoglycan and a mannose-rich glycoconjugate in corpora amylacea of the brain by immunocytochemical and lectin-binding methods. J. Neuroimmunol. 14:1987;49-60.
115. Livni N., Behar A.J., Lafair J.S. Unusual amyloid bodies in human liver: ultrastructural and freeze-etching studies. Isr. J. Med. Sci. 13:1977;1163-1170.
116. Loeffler K.U., Edward D.P., Tso M.O.M. Tau-2 immunoreactivity of corpora amylacea in the human retina and optic nerve. Invest. Ophthalmol. Vis. Sci. 34:1993;2600-2601.
117. Loiseau H., Marchal C., Vital A.S., Vital C., Rouger A., Loiseau P. Occurrence of polyglucosan bodies in temporal lobe epilepsy. J. Neurol. Neurosurg. Psychiatry. 55:1992;1092-1093.
118. Loiseau H., Marchal C., Vital A., Vital C., Rougier A., Loiseau P. Polyglucosan bodies: an unusual discovery in a case of temporal epilepsy. Review of the literature. Rev. Neurol. 149:1993;192-197.
119. Lossos A., Barash V., Soffer D., Argov Z., Gomori M., Ben-Narian Z., Abramsky O., Steiner I. Hereditary branching enzyme dysfunction in Adult Polyglucosan Body Disease: a possible metabolic cause in two patients. Ann. Neurol. 30:1991;655-662.
120. Loupal G. Über eine der Myoklonuskörperkrankeit (morbus Lafora): des Menschen und des Hundes morphologisch ähnliche Speicherkrankeit bei einem Nymphensittich (Nymphicus hallandicus). Zlblatt für Veterinarmed. 32:1985;502-511.
121. McDonald T.D., Faust P.L., Bruno C., DiMauro S., Goldman J.E. Polyglucosan body disease simulating amyotrophic lateral sclerosis. Neurology. 43:1993;785-790.
122. McGeer P.L., McGeer E.G. Complement proteins and complement inhibitors in Alzheimer's Disease. Res. Immunol. 143:1992;621-624.
123. Mackenzie C.D., Johnson R.P. Lafora disease in a dog. Austr. Vet. J. 52:1976;144.
124. Mackenzie J.M. Polyglucosan bodies are not an unusual finding in temporal lobe epilepsy. J. Neurol. Neurosurg. Psychiatry. 56:1993;577.
125. Mackenzie J.M. The surgical pathology of epilepsy: a study of 40 cases. Neuropathol. Appl. Neurobiol. 17:1991;526. (Abstr.).
126. V.A. McKusick. Mendelian Inheritance in Man. 8th (edn.), John Hopkins University Press, Baltimore, 1988, 1091-1092.
127. McMaster K.R., Powers J.M., Hennigar G.R., Wohltmann H.J., Farr G.H. Nervous system involvement in Type IV glycogenosis. Arch. Pathol. 103:1979;105-111.
128. Maddox I.O., Descartes M., Collins J., Keating J., Rosenfeld S., Palmer C., Carroll A.J. Identification of a recombination event narrowing the Lafora disease gene region. J. Med. Genet. 34:1997;590-591.
129. Maines M.D. Heme oxygenase: function, multiplicity, regulatory mechanisms and clinical applications. FASEB J. 2:1988;2557-2568.
130. Martin J.E., Mather K., Swash M., Garafalo O., Leigh P.N., Anderton B.H. Heat shock protein expression in corpora amylacea in the central nervous system: clue to their origin. Neuropathol. Appl. Neurobiol. 17:1991;113-119.
131. Marx A.J., Gueft B., Moskal J.F. Prostatic corpora amylacea. A study with the electron microscope and electron probe. Arch. Pathol. 80:1965;487-494.
132. Michaels L., Levine C. Pulmonary corpora amylacea. J. Pathol. Bacteriol. 74:1957;49-56.
133. Mittal K.R., Olszewski W.A. Widening of inter-Purkinje cell distances in association with corpora amylacea. J. Gerontol. 40:1985;700-702.
134. Mizutani T., Satoh J., Morimatsu Y. Axonal polyglucosan body in the ventral posterolateral nucleus of the human thalamus in relation to aging. Acta Neuropathol. 74:1987;9-12.
135. Morris J.H., Hudson J.R., Weddell A. A study of degeneration and regeneration in the divided rat sciatic nerve based on electron microscopy III Changes in the axons of the proximal stump. Z. Zellforsch. Mikro. Anat. 124:1972;131-164.
136. Mydlarski M.B., Liang J.-J., Schipper H.M. Role of cellular stress responses in the biogenesis of cytsteamine-induced astrocyte inclusions in primary culture. J. Neurochem. 61:1993;1755-1765.
137. Namba M. The microscopic, submicroscopic structure and histochemistry of the inclusion body seen in myoclonic epilepsy. Bull. Yamaguchi Med. Sch. 11:1964;103-138.
138. Nase S., Kunze K.P., Sigmund M., Schroeder J.M., Shin Y., Hanrath P. A new variant of type IV glycogenosis with primary cardiac manifestation and complete branching enzyme deficiency. Eur. Heart J. 16:1995;1698-1704.
139. Neville H.E., Brooke M.H., Austin J.H. Studies in myoclonus epilepsy. (Lafora body form) IV. Skeletal muscle abnormalities. Arch. Neurol. 30:1974;466-474.
140. Nishimura R.N., Ishak K.G., Reddick R., Porter R., James S., Barranger J.A. Lafora disease: diagnosis by liver biopsy. Ann. Neurol. 8:1980;409-415.
141. Nikaido T., Austin J., Stukenbrok H. Studies in myoclonus epilepsy: 3. The effects of amylolytic enzymes on the ultrastructure of Lafora bodies. J. Histochem. Cytochem. 19:1971;382-385.
142. Nolan C.C., Brown A.W. Reversible neuronal damage in hippocampal pyramidal cells with triethyllead: the role of astrocytes. Neuropathol. Appl. Neurobiol. 15:1989;441-458.
143. Norio K., Koskiniema M. Progressive myoclonic epilepsy: genetic and nosological aspects with special reference to 107 Finnish patients. Clin. Genet. 15:1979;382-398.
144. Oder D.L., Janeway R., Pearce L.A., Ravens J.R. Progressive myoclonus epilepsy with Lafora Bodies: II. Studies of ultrastructure. Arch. Neurol. 16:1967;583-594.
145. Okamoto K., Llena J.F., Hirano A. Atype of adult polyglucosan body disease. Acta Neuropathol. 58:1982;73-77.
146. Orthner H., Becker P.E., Müller D. Recessiv erbliche amyotrophische Lateralsklerose mit 'Lafora-Körpern'. Arch. Psychiat. Nervenkr. 217:1973;387-412.
147. Ota I.M., Gilbert J.M., Clarke S. Two major isozymes of the protein D-aspartyl/L-isoaspartyl methyl-transferase from human erythrocytes. Biochem. Biophys. Res. Commun. 151:1988;1136-1143.
148. Palmucci L., Anzil A.P., Luh S. Intra-astrocytic glycogen granules and corpora amylacea stain positively for polyglucosans: a cytochemical contribution on the fine structure polymorphism of particulate polysaccharides. Acta Neuropathol. 57:1982;99-102.
149. Pedersen E., Grynderup V., Kissmeyer-Nielsen F., Nielsen J., Poulsen J.H., Reske-Nielsen E. Familial progressive myoclonic epilepsy. J. Neurol. Sci. 53:1982;305-320.
150. Peeress N.S., DiMauro S., Roxburgh V.A Adult polysaccharidosis. Clinicopathological, ultrastructural and biochemical features. Arch. Neurol. 36:1979;840-845.
151. Peres J., Perentes E. Light-induced retinopathy in the albino rat in long-term studies: an immunohistochemical and quantitative approach. Exp. Toxicol Pathol. 4:1994;229-235.
152. Powell H.C., Ward H.W., Garrett R.S., Orloff M.J., Lampert P.W. Glycogen accumulation in the nerves and kidney of chronically diabetic rats. J. Neuropathol. Exp. Neurol. 38:1979;114-127.
153. Probst A., Sandoz P., Vanoni C., Baumann J.U. Intraneuronal polyglucosan storage restricted to the lateral pallidum (Bielschowsky bodies). A Golgi, light- and electronmicroscopic study. Acta Neuropathol. 51:1980;119-126.
154. Ramsey H. Ultrastructure of corpora amylacea. J. Neuropathol. Exp. Neurol. 24:1965;25-39.
155. Ramón y Cajal S., Blanes A., Martinez A., Saenz E., Gutierrez M. Lafora's Disease. An ultrastructural and histochemical study. Acta Neuropathol. 30:1974;189-196.
156. Reed jr G.B., Dixon J.F.P., Neustein H.B., Donnell G.N., Landing B. Type IV glycogenosis. Patient with absence of branching enzyme α-1,4-glucan: α-1,6-glucan 6-glycosyl transferase. Lab. Invest. 19:1968;546-557.
157. Renkawek K., Bosman G.J.C.G.M. Anion exchange proteins are a component of corpora amylacea in Alzheimer disease brain. NeuroReport. 6:1995;929-932.
158. Rifai Z., Klitzke M., Tawil R., Kazee A.M., Shanske, DiMauro S., Griggs R.C. Dementia in polyglucosan body disease. Arch. Neurol. 51:1994;90-94.
159. Robitaille Y., Carpenter S., Karpati G., Dimauro S. A distinct form of adult polyglucosan body disease with massive involvement of central and peripheral neuronal processes and astrocytes. A report of four cases and a review of the occurrence of polyglucosan bodies in other conditions. Brain. 103:1980;315-336.
160. Röcken C., Linke R.P., Saeger W. Corpora amylacea in the lung, prostate and uterus. Pathol. Res. Pract. 192:1996;998-1006.
161. Roizin I., Ferraro A. Myoclonus epilepsy:clinicopathological report of a case. J. Neuropathol. Exp. Neurol. 1:1942;297-311.
162. Rosai J. Basophilic (mucoid) degeneration of the myocardium and corpora amylacea of central nervous system: two examples of abnormal glycogen metabolism. Am. J. Pathol. 55:1969;66a. (abstr.).
163. Rosai J., Lascano E.F. Basophilic (mucoid) degeneration of myocardium. Am. J. Pathol. 61:1970;99-111.
164. Roukema P.A., Oderkerk C.H. Isolation and preliminary characterisation of corpora amylacea from human brain. Psychiatr. Neurol. Neurosurg. 73:1970;87-96.
165. Sainz J., Minassian B.A., Serratosa J.M., Gee M.N., Sakamoto L.M., Iranmanesh R., Bohlega S., Baumann R.J., Ryan S., Sparkes R.S., Delgado-Escueta A.V. Lafora progressive myoclonus epilepsy: narrowing the chromosome 6q24 locus by recombinations and homozygosities [letter]. Am. J. Hum. Genet. 61:1997;1205-1209.
166. Sakai M., Austin J., Witmer F., Trueb L. Studies of corpora amylacea: I. Isolation and preliminary characterization by chemical and histochemical techniques. Arch. Neurol. 21:1969;526-544.
167. Sakai M., Austin J., Witmer F., Trueb L. Studies in myoclonus epilepsy (Lafora body form): II. Polyglucosans in the systemic deposits of myoclonus epilepsy and in corpora amylacea. Neurology. 20:1970;160-176.
168. Sarlin M.B., Kloepfer H.W., Mickle W.A., Heath R.G. The detection of carriers in hereditary myoclonic epilepsy. Acta Genet. Med. Gemell. 9:1960;466-471.
169. Sbarbati A., Carner M., Colletti V., Osculati F. Extrusion of corpora amylacea from the marginal glia at the vestibular root entry zone. J. Neuropathol. Exp. Neurol. 55:1996;196-201.
170. Sbarbati A., Carner M., Colletti V., Osculati F. Myelin-Containing Corpora Amylacea In Vestibular Root Entry Zone. Ultrastruct. Pathol. 20:1996;437-442.
171. Schipper H.M. Experimental induction of corpora amylacea in adult rat brain. Microsc. Res. Tech. 43:1998;43-48.
172. Schipper H.M., Cisse S. Mitochondrial constituents of corpora-amylacea and autofluorescent astrocytic inclusions in senescent human brain. Glia. 14:1995;55-64.
173. Schipper H.M., Cisse S., Stopa E.G. Expression of heme oxygenase-1 in the senescent and Alzheimer-diseased brain. Ann. Neurol. 37:1995;758-768.
174. Schipper H.M., Vininsky R., Brull R., Samall L., Brawer J.R. Astrocyte mitochondria: a substrate for iron deposition in the aging rat substantia nigra. Exp. Neurol. 152:1998;188-196.
175. Schochet S.S., McCormick W.F., Zellweger H. Type IV glycogenosis (amylopectinosis). Arch. Pathol. 90:1970;354-363.
176. Schröder J.M., May R., Shin Y.S., Sigmund M., Nasse-Hüppmeier S. Juvenile hereditary polyglucosan body disease with complete branching enzyme deficiency (type IV glycogenosis). Acta Neuropathol. 85:1993;419-430.
177. Schwarz G.A., Yanoff M. Lafora's Disease. Arch. Neurol. 32:1965;172-188.
178. Scolding N.J., Morgan B.P., Houstan A., Campbell A.K., Linington C., Compston D.A.S. Normal rat serum cytotoxicity against syngeneic oligodendrocytes; complement activation and attack in the absence of anti-myelin antibodies. J. Neurol. Sci. 89:1989;289-300.
179. Scotti T.M. Basophilic (mucinous) degeneration of the myocardium. Am. J. Clin. Pathol. 25:1955;994-1011.
180. Scotti T.M. Basophilic degeneration in the myocardium in a whale and a horse. Am. J. Clin. Pathol. 38:1962;530-532.
181. Serratosa J.M., DelgadoEscueta A.V., Posada I., Shih S., Drury I., Berciano J., Zabala J.A., Antunez M.C., Sparkes R.S. The gene for progressive myoclonus epilepsy of the Lafora type maps to chromosome 6q. Hum. Mol. Genet. 4:1995;1657-1663.
182. Servidei S., Riepe R.E., Langston C., Tani L.Y., Bricker J.T., Crisp-Lindgren N., Travers H., Armstrong D., DiMauro S. Severe cardiomyopathy in branching enzyme deficiency. J. Pediatr. 111:1987;51-56.
183. Sidbury J.B., Mason J., Burns W.B., Ruebner B.H. Type IV glycogenosis: report of a case proven by characterization of glycogen and studied at necropsy. Bull. John Hopk. Hosp. 111:1964;157-181.
184. Simmons M.M. Lafora disease in the cow? J. Comp Pathol. 110:1994;389-401.
185. Singhrao S.K., Neal J.W., Newman G.R. Corpora amylacea could be an indicator of neurodegeneration. Neuropathol. Appl. Neurobiol. 19:1993;269-276.
186. Singhrao S.K., Neal J.W., Piddlesden S.J., Newman G.R. New immunocytochemical evidence for a neuronal/oligodendroglial origin for corpora amylacea. Neuropathol. Appl. Neurobiol. 20:1994;66-73.
187. Singhrao S.K., Morgan B.P., Neal J.W., Newman G.R. Functional role for corpora amylacea based on evidence from complement studies. Neurodegeneration. 4:1995;335-345.
188. Sokal E.M., van Hoof F., Alberti D., de Ville de Goyet J., de Barsy T., Otte J.B. Progressive cardiac failure following orthotopic liver transplantation for type IV glycogenosis. Eur. J. Pediatr. 151:1992;203-300.
189. Spencer H. Mucoid degeneration of heart muscle. J. Pathol. Bacteriol. 62:1950;653-654.
190. Spencer P.S., Thomas P.K. Ultrastructural studies of the dying back process II the sequestration and removal by Schwann cells and oligodendrocytes of organelles from normal and diseased axons. J. Neurocytol. 3:1974;763-783.
191. Stam F.C., Roukema P.A. Histochemical and biochemical aspects of corpora amylacea. Acta Neuropathol. 25:1973;95-102.
192. Stayaert A., Cisse S., Merhi Y., Kalbakji A., Reid N., Gauvreau D., Lacoste-Royal G. Purification and polypeptide composition of corpora amylacea from aged brain. J. Neurosci. Methods. 31:1990;59-64.
193. Steele H.D., Kinley G., Leuchtenberger C., Lieb E. Polysaccharide nature of corpora amylacea. Arch. Pathol. 54:1952;94-97.
194. Sugiyama H., Hainfellner J.A., Lassmann H., Indravasu S., Budka H. Uncommon types of polyglucosan bodies in the human brain-distribution and relation to disease. Acta Neuropathol. 86:1993;484-490.
195. Sun C.N. Ultrastructural study of corpora amylacea in human thyroid gland. Exp. Pathol. 23:1983;219-225.
196. Suzuki Y., Kamiya S., Ohta K., Suu S. Lafora-like bodies in a cat. Acta Neuropathol. 48:1979;55-58.
197. Suzuki Y., Ohta K., Suu S. Correlative studies of axonal spheroids and Lafora-like bodies in aged dogs. Acta Neuropathol. 48:1979;77-812.
198. Suzuki Y., Ohta K., Kamya S., Suu S. Topographic distribution patterns of Lafora-like bodies in the spinal cord of some animals. Acta Neuropathol. 49:1980;2159-2161.
199. Suzuki K., David E., Kutschman B. Presenile dementia with 'Lafora-like' intraneuronal inclusions. Arch. Neurol. 25:1971;69-80.
200. Agari K.M., Nakamura H. Intra-axonal corpora amylacea in ventral and lateral horns of the spinal cord. Acta Neuropathol. 11:1975;151-158.
201. Takahashi K., Iwagata K., Nakamura H. Intra-axonal corpora amylacea in the CNS. Acta Neuropathol. 37:1977;165-167.
202. Tamura S., Takahashi T., Kawamura S., Ishihara T. Basophilic degeneration of the myocardium: histological, immunohistochemical and immuno-electronmicroscopic studies. Histopathology. 26:1995;501-508.
203. Tani E., Evans J.B. Electron microscope studies of cerebral swelling II Alterations of myelinated fibres. Acta Neuropathol. 4:1965;604-623.
204. Tate-Ostroff B., Majocha R.E., Marotta C.A. Identification of cellular and extracellular sites of amyloid precursor protein extracytoplasmic domain in normal and Alzheimer disease brains. Proc. Natl. Acad. Sci. U.S.A. 86:1989;745-749.
205. Tigges J., Herndon J.G., Rosene D.L. Mild age-related changes in the dentate gyrus of adult rhesus monkeys. Acta Anat. 153:1995;39-48.
206. Tinuper P., Plazzi G., Monari L., Sangiorgi S., Pellissier J.-F., Cerullo A., Provini F., Capellari S., Baruzzi A., Lugaresi E., Montagna P. Arylsulfatase A pseudodeficiency and Lafora bodies in a patient with progressive myoclonic epilepsy. Epilepsia. 35:1994;332-335.
207. Toga M., Dubois D., Hassoun J. Ultrastructure des corps de Lafora. Acta Neuropathol. 10:1968;132-142.
208. Tokutake S., Nagase H., Morisaki S., Oyanagi S. X-ray microprobe analysis of corpora amylacea. Neuropathol. Appl. Neurobiol. 21:1995;269-273.
209. Tomchick T.L. Familial Lafora's Disease in the beagle dog. Fed Proc. 32:1973;821. (abstract).
210. Uchida K., Yoshino T., Yamaguchi R., Tateyama S., Kimoto Y., Najayama H., Goto N. Senile plaques and other senile changes in the brain of an aged American Black Bear. Vet. Pathol. 32:1955;412-414.
211. Ule G., Volk B. Torpide verlaufende Degeneration des äusseren Pallidumgliedes mit Bielschowsky-körperchen. J. Neurol. 210:1975;191-198.
212. Vanderhaeghen J.J. Correlation between ultrastructure and histochemistry of Lafora bodies. Acta Neuropathol. 17:1971;24-36.
213. Vanderhaeghen J.J., Manil J., Franken L., Cappel R. Deux observations de spasme de torsion accompagne de choreoathetose avec nombreux corps de Laforà dans la partie externe du globus pallidus. Acta Neuropathol. 9:1967;45-52.
214. van Heycop ten Ham M.W., de Jager H. Progressive myoclonus epilepsy with Lafora bodies. Epilepsia. 4:1963;95-119.
215. van Paesschen W., Revesz T., Duncan J.S. Corpora amylacea in hippocampal sclerosis. Neurol. Neurosurg. Psychiatr. 63:1997;513-515.
216. Virchow R. Ueber eine Gehirn und Rückenmark des Menschen aufgefundene Substanz mit der chemischen Reaction der Cellulose. Arch. Path. Anat. u Physiol. u Klin. Med. 6:1854;135-138.
217. Vos A.J.M., Joosten E.M.G., Gabreël-Festen A.A.W.M. Adult polyglucosan disease: clinical and nerve biopsy findings in two cases. Ann Neurol. 13:1983;440-444.
218. Weiss J., Schröder J.M. Adult polyglucosan myopathy with subclinical peripheral neuropathy: case report and review of diseases associated with polyglucosan body accumulation. Clin. Neuropathol. 7:1988;271-279.
219. Wirak D.O., Bayney R., Ramabhadran T.V., Fracasso R.P., Hart J.T., Hauer P.E., Hsiau P., Pekar S.K., Scangos G.A., Trapp B.D., Unterbeck A.J. Deposits of amyloid β protein in the central nervous system of transgenic mice. Science. 253:1991;323-325.
220. Woodford B., Tso M.O.M. An ultrastructural study of the corpora amylacea of the optic nerve head and retina. Am. J. Ophthalmol. 90:1980;492-502.
221. Yagishita S., Itoh Y., Nakano T., Amano N., Yokoi S., Hasegawa O., Tanaka T. Pleomorphic intra-neuronal polyglucosan bodies mainly restricted to the pallidum. A case report. Acta Neuropathol. 62:1983;159-163.
222. Yan S.D., Schmidt A.M., Anderson G.M., Zhang J., Brett J., Zou Y.S., Pinsky D., Stern D. Enhanced cellular oxidant stress by interaction of advanced glycation end products with their receptors/binding proteins. J. Biol. Chem. 269:1994;9889-9897.
223. Yan S.D., Chen X., Schmidt A.M., Brett J., Goodman G., Zou Y.S., Scott C.W., Caputo C., Frappier T., Smith M.A., Perry G., Yen S.H., Stern D. Glycated tau protein in Alzheimer's disease: a mechanism for induction of stress. Proc. Natl. Acad. Sci. U.S.A. 91:1994;7787-7791.
224. Yanai T., Masegi T., Iwanaka M., Yoshida K., Ueda K., Suzuki Y., Kamiya S. Polyglucosan bodies in the brain of a cow. Acta Neuropathol. 88:1994;75-77.
225. Yamanami S., Ishihara T., Takahashi M., Ushino F. Comparative study of intraneuronal polyglucosan bodies in brains from patients with Lafora body disease and aged dogs. Acta Pathol. Jpn. 42:1992;787-792.
226. Yokoi S., Austin J., Witmer F., Sakai M. Studies in myoclonus epilepsy (Lafora Body Form): I. Isolation and preliminary characterization of Lafora bodies in two cases. Arch. Neurol. 19:1968;15-33.
227. Yokoi S., Aihara Y., Maeda S. The myocardium in Lafora disease. Acta Neuropathol. 33:1975;343-349.
228. Yokoi S., Nakayama H., Negishi T. Biochemical studies on tissues from a patient with Lafora Disease. Clin. Chim. Acta. 62:1975;415-423.
229. Yokota T., Ishihara T., Yoshid A., Takahashi H., Uchino F., Hamanaka S. Monoclonal antibody against polyglucosan isolated from the myocardium of a patient with Lafora disease. Neuropathol. Exp. Neurol. 47:1988;572-577.
230. Zamora A.J., Cavanagh J.B., Kyu M.H. Ultrastructural responses of astrocytes to portocaval anastomosis. J. Neurol Sci. 18:1973;23-45.
231. Zimmerman C.P., Gold A.M. Glycogen branching enzyme in Lafora myoclonus epilepsy. Biochem. Med. 28:1982;83-93.